Equity Research Medical Care Facilities

Should You Buy Community Health Systems, Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 3/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Community Health Systems, Inc. (CYH) occupies a solid middle-ground position with a Quality of Company score of 7.1/10. At the current market price of $2.97, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.

The short answer: 3 of 3 CirclFi valuation models project upside for Community Health Systems, Inc. (CYH) at $2.97 — the model consensus leans bullish, with a Quality Score of 7.1/10 and Value-Trap risk of 22/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 3 of 3 models see upside — majority bullish
  • Quality Score: 7.1/10 — Strong — above-average quality
  • Value Trap Risk: 22/100 — Minimal — healthy fundamentals
  • Fair Value Range: $3.06 – $5.53 (81% spread)

Bullish Models

3 / 3

Bearish Models

0 / 3

Quality Score

7.1 /10

Strong — above-average quality

Value Trap Risk

22 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

3 /13
Active Models

Avg. confidence: 68%

What Is the Investment Case for Community Health Systems, Inc. (CYH) in 2026?

What Is the Bull Case vs the Bear Case for Community Health Systems, Inc. (CYH)?

Bull case versus bear case for Community Health Systems, Inc. (CYH) at $2.97, derived from 3 active CirclFi valuation models on 2026-09-15.
Bull case — $5.53 target (+86.1%) Bear case
According to the CirclFi Quality of Company (QOC) framework, Community Health Systems, Inc.'s rating of 7.1/10 signals strong fundamentals — high-quality businesses tend to compound value more reliably. No active model flags significant downside for CYH. The low Value Trap score paints a constructive picture.
According to the CirclFi Deep Alpha Valuation Engine, 2 of 3 models identify upside from $2.97 to a median fair value of $3.39, indicating the market hasn't fully priced in Community Health Systems, Inc.'s earnings power.
According to the CirclFi Deep Alpha Valuation Engine, the RCMH-DCF model targets a fair value of $5.53 (+86.1%), anchoring the bull case with a methodology that provides a differentiated analytical lens.

How Does CYH Compare to Its Medical Care Facilities Peers?

ASTH Astrana Health, Inc.
7.1
DCGO DocGo Inc.
6.8
AUNA Auna SA
7.2
INNV InnovAge Holding Cor
6.8
LFST LifeStance Health Gr
7.2
AMN AMN Healthcare Servi
6.7
AMS American Shared Hosp
5.9
PARK Park Dental Partners
3.9

Valuation data pages: ASTH · DCGO · AUNA · INNV · LFST · AMN · AMS · PARK · ARDT · ADUS · NHC

See full Medical Care Facilities rankings →

Which Other Stocks Score Like CYH on Quality?

Closest companies to CYH’s Quality of Company score of 7.1/10, across all industries.

Why Do CirclFi’s 3 Models Disagree on CYH?

Spread

81%

Fair Value Range

$3.06 – $5.53

A 81% spread represents moderate disagreement. The models agree on direction but differ on magnitude.

Most Bullish

RCMH-DCF

$5.53 (+86.1%)

Most Bearish

EPV

$3.06 (+2.9%)

What Are the Biggest Risks of Buying CYH Stock?

Macro/Sector Risk

Medical Care Facilities headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View CYH Data Page →

So Is Community Health Systems, Inc. (CYH) Worth Buying in 2026?

Community Health Systems, Inc. leans positive in our analysis — 2/3 models bullish, median fair value of $3.39 vs. $2.97, QOC 7.1/10. The case is constructive but not overwhelming, and the 0 dissenting models shouldn't be dismissed. Position sizing should reflect this moderate conviction level.

These are quantitative model outputs, not investment recommendations. Community Health Systems, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About CYH Stock?

Should I buy CYH stock right now?

Based on CirclFi's multi-model analysis, 3 of 3 models see upside for CYH at $2.97. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 7.1/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Community Health Systems, Inc.?

Key risks include: limited model coverage (3/13 active), reducing analytical confidence; general market and sector-specific risks affecting Medical Care Facilities companies. Always diversify and consult a financial advisor.

How does CYH compare to its competitors?

Among Medical Care Facilities peers, CYH holds a Quality Score of 7.1/10. Comparable companies include ASTH (QOC 7.1), DCGO (QOC 6.8), AUNA (QOC 7.2). The relative ranking helps investors identify whether CYH offers better fundamental quality than alternatives in the same sector.

Is CYH a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CYH's Quality Score of 7.1/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy CYH at?

CirclFi does not provide target buy prices or price alerts. However, our 3 active models produce fair value estimates ranging from $3.06 to $5.53. At $2.97, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for CYH.

View CYH Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →